Health AI Startup Biofourmis Hits $1.3 Billion Valuation With Series D Funding

Biofourmis, a startup developing digital therapeutics and artificial intelligence to remotely monitor patients, said its valuation hit $1.3 billion after raising a $300 million Series D funding round led by General Atlantic.